Mirtazapine indirectly enhances serotonergic transmission by antagonizing 5-HT2 and 5-HT3 receptors, thereby increasing 5-HT1A receptor activity, which may contribute to serotonin syndrome in overdose settings [5, 6]. Here, HTR1A is linked to serotonin syndrome.